Journal Watch · Frontiers in Immunology · 2026

Cytokines in patients with Posner-Schlossman syndrome.

Note: CECD, corneal endothelial cell density; RECL, relative decrease in CECD loss between the affected eye and the fellow eye.

Liu Y, Li S, Kong X et al.Frontiers in Immunology3 min readPharma relevance 55/100

DOI: 10.3389/fimmu.2026.1739027PMID: 41694376Study type: clinical study

TL;DR

Note: CECD, corneal endothelial cell density; RECL, relative decrease in CECD loss between the affected eye and the fellow eye.

Key findings

  • Notably, IL-6 levels positively correlated with IL-8 and IL-10, and also showed significant associations with IOP (r = 0.395, P = 0.007) and relative endothelial cell loss (RECL) (r = 0.453, P = 0.039).<h4>Conclusion</h4>Distinct inflammatory cytokine profiles in the AH of PSS patients suggest a prominent immune response potentially contributing to disease pathogenesis.
  • IL-6 may serve as a biomarker reflecting both inflammation and tissue damage in PSS.
  • Note: CECD, corneal endothelial cell density; RECL, relative decrease in CECD loss between the affected eye and the fellow eye.

Numbers at a glance (from the abstract)

P<0.05P = 0.007P = 0.039

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Clinical data including corneal endothelial cell density, visual acuity, intraocular pressure (IOP), and visual field were also recorded.<h4>Results</h4>The AH levels of IL-1β, IL-5, IL-6, IL-8, IL-10, IFN-γ, and TNF-α were significantly elevated in PSS patients compared to controls (<i>P</i> < 0.05), with IL-1β, IL-6, IL-10, and IFN-γ levels also significantly higher than in POAG patients. ROC curve analysis demonstrated diagnostic value of these four cytokines in differentiating PSS from POAG (P<0.05). No significant differences in cytokine levels were observed between CMV DNA-positive and -negative PSS samples.

Full abstract (original)

Background: <h4>Purpose</h4>To investigate the inflammatory cytokine profiles in the aqueous humor (AH) of patients with Posner-Schlossman syndrome (PSS) and evaluate their correlations with key ophthalmic parameters.<h4>Methods</h4>Aqueous humor samples were collected from 31 eyes with PSS, 26 eyes with primary open-angle glaucoma (POAG), and 20 eyes with age-related cataract (ARC, control group) at the Eye and ENT Hospital of Fudan University. A multiplex bead-based flow cytometric immunoassay was performed to quantify the concentrations of interleukins (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17), tumor necrosis factor-alpha (TNF-α), and interferons (IFN-α, IFN-γ). Simultaneously, the presence of cytomegalovirus (CMV) DNA in PSS samples was assessed by PCR.

What they did: Clinical data including corneal endothelial cell density, visual acuity, intraocular pressure (IOP), and visual field were also recorded.<h4>Results</h4>The AH levels of IL-1β, IL-5, IL-6, IL-8, IL-10, IFN-γ, and TNF-α were significantly elevated in PSS patients compared to controls (<i>P</i> < 0.05), with IL-1β, IL-6, IL-10, and IFN-γ levels also significantly higher than in POAG patients. ROC curve analysis demonstrated diagnostic value of these four cytokines in differentiating PSS from POAG (P<0.05). No significant differences in cytokine levels were observed between CMV DNA-positive and -negative PSS samples.

Results & conclusions: Notably, IL-6 levels positively correlated with IL-8 and IL-10, and also showed significant associations with IOP (r = 0.395, P = 0.007) and relative endothelial cell loss (RECL) (r = 0.453, P = 0.039).<h4>Conclusion</h4>Distinct inflammatory cytokine profiles in the AH of PSS patients suggest a prominent immune response potentially contributing to disease pathogenesis. IL-6 may serve as a biomarker reflecting both inflammation and tissue damage in PSS. Note: CECD, corneal endothelial cell density; RECL, relative decrease in CECD loss between the affected eye and the fellow eye.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1739027 · PubMed 41694376.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Frontiers in Immunology study find?

Note: CECD, corneal endothelial cell density; RECL, relative decrease in CECD loss between the affected eye and the fellow eye.

What type of study is this?

It is a clinical study, published in Frontiers in Immunology in 2026. Clinical data including corneal endothelial cell density, visual acuity, intraocular pressure (IOP), and visual field were also recorded.<h4>Results</h4>The AH levels of IL-1β, IL-5, IL-6, IL-8, IL-10, IFN-γ, and TNF-α were significantly elevated in PSS patients compared to controls (<i>P</i> < 0.05), with IL-1β, IL-6, IL-10, and IFN-γ levels also significantly higher than in POAG patients.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1739027. PubMed ID: 41694376. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Liu Y, Li S, Kong X et al.. Cytokines in patients with Posner-Schlossman syndrome.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1739027.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/cytokines-in-patients-with-posner-schlossman-syndrome-739027/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides